Showing results (121-130 of 168) with videos related to

Sort By:
Pageof 17
Virology|May 15, 2007
Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanionsClaire Bertaux, Dirk Daelemans, Laurent Meertens, et al.
The Journal of Clinical Investigation|October 20, 2007
Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voidingThomas Gevaert, Joris Vriens, Andrei Segal, et al.
Nature Communications|February 7, 2018
Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genesJasper Edgar Neggers, Bert Kwanten, Tim Dierckx, et al.
Chemical Biology & Drug Design|August 7, 2018
Design, synthesis, and antiviral evaluation of novel hydrazone-substituted thiophene[3,2-d]pyrimidine derivatives as potent human immunodeficiency virus-1 inhibitorsZhao Wang, Dongwei Kang, Meng Chen, et al.
Oncotarget|November 20, 2018
Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progressionAmro Aboukameel, Irfana Muqbil, Erkan Baloglu, et al.
ACS Medicinal Chemistry Letters|April 20, 2018
Discovery of Novel Diarylpyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the "NNRTI Adjacent" Binding SiteZhipeng Huo, Heng Zhang, Dongwei Kang, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2020
Discovery of potential dual-target prodrugs of HIV-1 reverse transcriptase and nucleocapsid protein 7Songkai Sun, Boshi Huang, Zhuo Li, et al.
Ebiomedicine|October 27, 2015
Human Exportin-1 is a Target for Combined Therapy of HIV and AIDS Related LymphomaEline Boons, Els Vanstreels, Maarten Jacquemyn, et al.
Journal of Virology|October 12, 2023
4-Octyl itaconate reduces influenza A replication by targeting the nuclear export protein CRM1Pau Ribó-Molina, Hauke J Weiss, Balasubramanian Susma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
The Second-Generation Exportin-1 Inhibitor KPT-8602 Demonstrates Potent Activity against Acute Lymphoblastic LeukemiaThomas Vercruysse, Jolien De Bie, Jasper E Neggers, et al.
Pageof 17